Russia's Vector Center Ready to Combat Mpox With Vaccine & Diagnostic Tools

© AP Photo / Jeenah MoonA family nurse practitioner prepares a syringe with the Mpox vaccine for inoculating a patient at a vaccination site in the Brooklyn borough of New York
A family nurse practitioner prepares a syringe with the Mpox vaccine for inoculating a patient at a vaccination site in the Brooklyn borough of New York - Sputnik Africa, 1920, 16.08.2024
Subscribe
The statements come as the WHO has warned that mpox, which is currently spreading in some countries in Central and West Africa, has the potential "to spread further across countries in Africa and possibly outside the continent."
The Russian state scientific center Vector has assured the public that it possesses sufficient quantities of the "OrthopoxVac" vaccine, effective against mpox.
This vaccine, developed by Vector in 2022, is based on a weakened smallpox virus and offers a high level of safety while providing protection against mpox, which belongs to the Orthopoxvirus family.
A vial containing the mpox vaccine and a syringe is set on the table at a vaccination clinic - Sputnik Africa, 1920, 16.08.2024
Sub-Saharan Africa
DR Congo Urgently Needs 3 Million Doses of Mpox Vaccine to Stop Outbreak, Health Ministry Says
In addition to the vaccine, Vector Center has also developed and registered a PCR test for the differential diagnosis of smallpox and mpox viruses. This comprehensive approach ensures Russia's preparedness for a potential outbreak.
Despite the recent WHO declaration of a public health emergency due to the spread of mpox, the Russian Federal Service for Oversight of Consumer Protection and Welfare announced that there is no immediate threat in Russia. They are, however, actively implementing measures to detect any potential cases of mpox.
Newsfeed
0